vs
Cronos Group Inc.（CRON）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
READING INTERNATIONAL INC的季度营收约是Cronos Group Inc.的1.1倍（$50.3M vs $44.5M），Cronos Group Inc.净利率更高（-4.1% vs -5.1%，领先1.0%），Cronos Group Inc.同比增速更快（47.0% vs -14.2%），Cronos Group Inc.自由现金流更多（$9.7M vs $4.1M），过去两年Cronos Group Inc.的营收复合增速更高（32.7% vs 5.6%）
Cronos集团是全球性大麻素企业，主营大麻种植、加工及相关衍生产品的分销业务，产品线覆盖健康补充剂、快消品及医用大麻品类，主要服务北美、欧洲、亚太地区的合规娱乐与医用消费市场，严格遵循各地监管要求保障产品品质。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
CRON vs RDI — 直观对比
营收规模更大
RDI
是对方的1.1倍
$44.5M
营收增速更快
CRON
高出61.1%
-14.2%
净利率更高
CRON
高出1.0%
-5.1%
自由现金流更多
CRON
多$5.6M
$4.1M
两年增速更快
CRON
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.5M | $50.3M |
| 净利润 | $-1.8M | $-2.6M |
| 毛利率 | 36.4% | — |
| 营业利润率 | -16.8% | -1.9% |
| 净利率 | -4.1% | -5.1% |
| 营收同比 | 47.0% | -14.2% |
| 净利润同比 | -104.2% | -14.5% |
| 每股收益（稀释后） | $-0.01 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRONRDI
| Q4 25 | $44.5M | $50.3M | ||
| Q3 25 | $36.3M | $52.2M | ||
| Q2 25 | $33.5M | $60.4M | ||
| Q1 25 | $32.3M | $40.2M | ||
| Q4 24 | $30.3M | $58.6M | ||
| Q3 24 | $34.3M | $60.1M | ||
| Q2 24 | $27.8M | $46.8M | ||
| Q1 24 | $25.3M | $45.1M |
净利润CRONRDI
| Q4 25 | $-1.8M | $-2.6M | ||
| Q3 25 | $26.0M | $-4.2M | ||
| Q2 25 | $-39.7M | $-2.7M | ||
| Q1 25 | $6.1M | $-4.8M | ||
| Q4 24 | $43.7M | $-2.2M | ||
| Q3 24 | $8.3M | $-7.0M | ||
| Q2 24 | $-8.8M | $-12.8M | ||
| Q1 24 | $-2.2M | $-13.2M |
毛利率CRONRDI
| Q4 25 | 36.4% | — | ||
| Q3 25 | 50.4% | — | ||
| Q2 25 | 43.4% | — | ||
| Q1 25 | 42.6% | — | ||
| Q4 24 | 35.7% | — | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 22.7% | — | ||
| Q1 24 | 17.7% | — |
营业利润率CRONRDI
| Q4 25 | -16.8% | -1.9% | ||
| Q3 25 | -1.4% | -0.6% | ||
| Q2 25 | -15.9% | 4.8% | ||
| Q1 25 | -12.6% | -17.2% | ||
| Q4 24 | -37.5% | 2.6% | ||
| Q3 24 | -98.2% | -0.6% | ||
| Q2 24 | -56.1% | -16.4% | ||
| Q1 24 | -63.1% | -16.7% |
净利率CRONRDI
| Q4 25 | -4.1% | -5.1% | ||
| Q3 25 | 71.4% | -8.0% | ||
| Q2 25 | -118.7% | -4.4% | ||
| Q1 25 | 19.0% | -11.8% | ||
| Q4 24 | 144.3% | -3.8% | ||
| Q3 24 | 24.4% | -11.7% | ||
| Q2 24 | -31.5% | -27.4% | ||
| Q1 24 | -8.9% | -29.4% |
每股收益（稀释后）CRONRDI
| Q4 25 | $-0.01 | $-0.11 | ||
| Q3 25 | $0.07 | $-0.18 | ||
| Q2 25 | $-0.10 | $-0.12 | ||
| Q1 25 | $0.02 | $-0.21 | ||
| Q4 24 | $0.12 | $-0.11 | ||
| Q3 24 | $0.02 | $-0.31 | ||
| Q2 24 | $-0.02 | $-0.57 | ||
| Q1 24 | $-0.01 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $831.8M | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | $1.1B | $-18.2M |
| 总资产 | $1.2B | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRONRDI
| Q4 25 | $831.8M | $10.5M | ||
| Q3 25 | $824.2M | $8.1M | ||
| Q2 25 | $834.4M | $9.1M | ||
| Q1 25 | $837.8M | $5.9M | ||
| Q4 24 | $858.8M | $12.4M | ||
| Q3 24 | $862.0M | $10.1M | ||
| Q2 24 | $848.2M | $9.3M | ||
| Q1 24 | $855.1M | $7.5M |
总债务CRONRDI
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CRONRDI
| Q4 25 | $1.1B | $-18.2M | ||
| Q3 25 | $1.1B | $-12.1M | ||
| Q2 25 | $1.1B | $-7.7M | ||
| Q1 25 | $1.1B | $-8.1M | ||
| Q4 24 | $1.1B | $-4.4M | ||
| Q3 24 | $1.1B | $1.6M | ||
| Q2 24 | $1.1B | $6.5M | ||
| Q1 24 | $1.1B | $18.0M |
总资产CRONRDI
| Q4 25 | $1.2B | $434.9M | ||
| Q3 25 | $1.2B | $435.2M | ||
| Q2 25 | $1.2B | $438.1M | ||
| Q1 25 | $1.2B | $441.0M | ||
| Q4 24 | $1.2B | $471.0M | ||
| Q3 24 | $1.2B | $495.7M | ||
| Q2 24 | $1.1B | $494.9M | ||
| Q1 24 | $1.1B | $494.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.8M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $9.7M | $4.1M |
| 自由现金流率自由现金流/营收 | 21.8% | 8.2% |
| 资本支出强度资本支出/营收 | 4.8% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $149.0K | $-2.9M |
8季度趋势，按日历期对齐
经营现金流CRONRDI
| Q4 25 | $11.8M | $4.3M | ||
| Q3 25 | $13.3M | $295.0K | ||
| Q2 25 | $2.8M | $1.6M | ||
| Q1 25 | $-2.1M | $-7.7M | ||
| Q4 24 | $7.7M | $8.0M | ||
| Q3 24 | $11.6M | $1.3M | ||
| Q2 24 | $1.7M | $-10.4M | ||
| Q1 24 | $-2.2M | $-2.8M |
自由现金流CRONRDI
| Q4 25 | $9.7M | $4.1M | ||
| Q3 25 | $8.8M | $-246.0K | ||
| Q2 25 | $-1.0M | $1.2M | ||
| Q1 25 | $-17.4M | $-8.0M | ||
| Q4 24 | $4.2M | $7.0M | ||
| Q3 24 | $5.2M | $-1.1M | ||
| Q2 24 | $1.0M | $-10.6M | ||
| Q1 24 | $-3.9M | $-4.7M |
自由现金流率CRONRDI
| Q4 25 | 21.8% | 8.2% | ||
| Q3 25 | 24.3% | -0.5% | ||
| Q2 25 | -3.0% | 1.9% | ||
| Q1 25 | -53.8% | -19.8% | ||
| Q4 24 | 13.8% | 12.0% | ||
| Q3 24 | 15.1% | -1.8% | ||
| Q2 24 | 3.7% | -22.7% | ||
| Q1 24 | -15.5% | -10.4% |
资本支出强度CRONRDI
| Q4 25 | 4.8% | 0.3% | ||
| Q3 25 | 12.3% | 1.0% | ||
| Q2 25 | 11.5% | 0.6% | ||
| Q1 25 | 47.3% | 0.6% | ||
| Q4 24 | 11.7% | 1.7% | ||
| Q3 24 | 18.7% | 4.0% | ||
| Q2 24 | 2.6% | 0.5% | ||
| Q1 24 | 6.8% | 4.3% |
现金转化率CRONRDI
| Q4 25 | — | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.34× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
